Edit |   |
---|---|
Antigenic Specificity | H1 complex, Human (Derlotuximab biosimilar) |
Clone | Derlotuximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human H1 Complex Recombinant Antibody. Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. |
Immunogen | n/a |
Other Names | Anti-H1 Complex Recombinant Antibody, Research Grade Derlotuximab, Anti-Human H1 Complex Recombinant Antibody, (131)I-chTNT-1/B, I-131 ch-TNT-1/B, Antibody Drug Analogues, Monoclonal Antibody, YR1082, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 340013-96-9 |
Catalog # | YR1082 |
Price | please inquire |
Order / More Info | H1 complex, Human (Derlotuximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |